Unknown

Dataset Information

0

Prognostic value of cardiopulmonary exercise testing in patients with systemic sclerosis.


ABSTRACT: BACKGROUND:Systemic sclerosis (SSc) is a severe rheumatic disease of the interstitial tissue, in which heart and lung involvement can lead to disease-specific mortality. Our study tests the hypothesis that in addition to established prognostic factors, cardiopulmonary exercise testing (CPET) parameters, particularly peak oxygen uptake (peakVO2) and ventilation/carbon dioxide (VE/VCO2)-slope, can predict survival in patients with SSc. SUBJECTS AND METHODS:We retrospectively assessed 210 patients (80.9% female) in 6 centres over 10?years with pulmonary testing and CPET. Survival was analysed with Cox regression analysis (adjusted for age and gender) by age, comorbidity (Charlson-Index), body weight, body-mass index, extensive interstitial lung disease, pulmonary artery pressure (measured by echocardiography and invasively), and haemodynamic, pulmonary and CPET parameters. RESULTS:Five- and ten-year survival of SSc patients was 93.8 and 86.9%, respectively. There was no difference in survival between patients with diffuse (dcSSc) and limited cutaneous manifestation (lcSSc; p?=?0.3). Pulmonary and CPET parameters were significantly impaired. Prognosis was worst for patients with pulmonary hypertension (p?=?0.007), 6-min walking distance ?35. Age (hazard ratio HR?=?1.23; 95% confidence interval CI: 1.14;1.41), VE/VCO2-slope (HR?=?0.9; CI 0.82;0.98), diffusion capacity (Krogh factor, HR?=?0.92; CI 0.86;0.98), forced vital capacity (FVC, HR?=?0.91; CI 0.86;0.96), and peakVO2 (HR?=?0.87; CI 0.81;0.94) were significantly linked to survival in multivariate analyses (Harrell's C?=?0.95). This is the first large study with SSc patients that demonstrates the prognostic value of peakVO2??35.

SUBMITTER: Ewert R 

PROVIDER: S-EPMC6884803 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prognostic value of cardiopulmonary exercise testing in patients with systemic sclerosis.

Ewert Ralf R   Ittermann Till T   Habedank Dirk D   Held Matthias M   Lange Tobias J TJ   Halank Michael M   Winkler Jörg J   Gläser Sven S   Olschewski Horst H   Kovacs Gabor G  

BMC pulmonary medicine 20191129 1


<h4>Background</h4>Systemic sclerosis (SSc) is a severe rheumatic disease of the interstitial tissue, in which heart and lung involvement can lead to disease-specific mortality. Our study tests the hypothesis that in addition to established prognostic factors, cardiopulmonary exercise testing (CPET) parameters, particularly peak oxygen uptake (peakVO<sub>2</sub>) and ventilation/carbon dioxide (VE/VCO<sub>2</sub>)-slope, can predict survival in patients with SSc.<h4>Subjects and methods</h4>We r  ...[more]

Similar Datasets

| S-EPMC7430148 | biostudies-literature
| S-EPMC5721737 | biostudies-literature
| S-EPMC8330933 | biostudies-literature
| S-EPMC9207317 | biostudies-literature
| S-EPMC7867820 | biostudies-literature
| S-EPMC11337671 | biostudies-literature
| S-EPMC2700081 | biostudies-other
| S-EPMC9320309 | biostudies-literature
| S-EPMC6478351 | biostudies-literature
| S-EPMC2000933 | biostudies-literature